New pill could calm restless legs – early trial underway
NCT ID NCT07453862
First seen Mar 08, 2026 · Last updated Apr 30, 2026 · Updated 6 times
Summary
This early-stage study is testing a new oral medication (a calcium channel modulator) to see if it can safely reduce the uncomfortable urge to move the legs in people with Restless Legs Syndrome (RLS). About 20 adults aged 18-75 with moderate-to-severe RLS will take the drug twice daily for 12 weeks. Researchers will track symptom changes and any side effects to determine if the drug is promising enough for larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEG SYNDROME (RLS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Capital Medical University Affiliated Beijing Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100050, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.